Efficacy and safety of anlotinib combined with 125I seed implantation for iodine-refractory thyroid cancer
Background and objectiveRadioiodine-refractory differentiated thyroid cancer (RAIR-DTC) remains challenging to treat due to a lack of effective therapies. This study aimed to evaluate the efficacy and safety of combining anlotinib with iodine-125 (125I) seed implantation in patients with RAIR-DTC.Me...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-08-01
|
| Series: | Frontiers in Endocrinology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1587412/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|